Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study
Clinical trial NCT05556291 · COMPLETED
Trial details
- NCT number
- NCT05556291
- Sponsor
- Getz Pharma
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-07-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.